IBT — International Biotechnology Trust Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsBalancedSmall Cap
- £266.07m
- £297.56m
- £44.54m
Annual cashflow statement for International Biotechnology Trust, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | C2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 53.6 | 28 | -22.3 | 8.18 | 41.2 |
| Non-Cash Items | -64.9 | -43.1 | 23.4 | 18.6 | 5.92 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.72 | 0.533 | 0.062 | 0.57 | -1.78 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.55 | -14.5 | 1.12 | 27.3 | 45.4 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.11 | 12 | -16.4 | -21.4 | -2.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -18.7 | -2.54 | -19.7 | 7.5 | 42.9 |